PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
XBIT vs. XBI
Performance
Return for Risk
Drawdowns
Volatility
Dividends

XBIT vs. XBI

Last updated Jun 4, 2026

XBIT (XBiotech Inc.) is a stock, while XBI (SPDR S&P Biotech ETF) is Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index. Over the past 10 years, XBIT returned -16.44%/yr vs 8.53%/yr for XBI. At a 0.32 correlation, their price movements are largely independent.

Performance

XBIT vs. XBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

Over the past 10 years, XBIT has underperformed XBI with an annualized return of -16.44%, while XBI has yielded a comparatively higher 8.53% annualized return.

XBIT

1D
-0.83%
1M
-6.27%
YTD
0.00%
6M
-7.72%
1Y
-17.30%
3Y*
-22.38%
5Y*
-30.37%
10Y*
-16.44%

XBI

1D
1.62%
1M
-2.75%
YTD
6.48%
6M
6.92%
1Y
58.25%
3Y*
14.73%
5Y*
0.59%
10Y*
8.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

XBIT vs. XBI - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
XBIT
XBiotech Inc.		0.00%-39.49%-1.25%13.96%-68.46%-17.46%-16.15%267.42%28.93%-61.07%
XBI
SPDR S&P Biotech ETF		6.48%35.89%1.01%7.60%-25.87%-20.45%48.33%32.56%-15.28%43.77%

Correlation

The correlation between XBIT and XBI is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Apr 16, 2015

0.32

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

XBiotech Inc.

SPDR S&P Biotech ETF

Often compared with XBIT:
XBIT vs. XBIOXBIT vs. AHCOXBIT vs. IBIOXBIT vs. IBBXBIT vs. IHIXBIT vs. SPYL.DEXBIT vs. VHT
Often compared with XBI:
XBI vs. IBBXBI vs. ARKGXBI vs. LABUXBI vs. BBHXBI vs. VOOXBI vs. IBBQXBI vs. FBIOX

Return for Risk

XBIT vs. XBI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
XBIT
XBIT Risk / Return Rank: 2727
Overall Rank
XBIT Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
XBIT Sortino Ratio Rank: 2626
Sortino Ratio Rank
XBIT Omega Ratio Rank: 2626
Omega Ratio Rank
XBIT Calmar Ratio Rank: 2626
Calmar Ratio Rank
XBIT Martin Ratio Rank: 2828
Martin Ratio Rank
XBI
XBI Risk / Return Rank: 7474
Overall Rank
XBI Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
XBI Sortino Ratio Rank: 6767
Sortino Ratio Rank
XBI Omega Ratio Rank: 6060
Omega Ratio Rank
XBI Calmar Ratio Rank: 9191
Calmar Ratio Rank
XBI Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBIT vs. XBI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

XBITXBIDifference
Sharpe ratioReturn per unit of total volatility
-0.33
2.30

-2.63

Sortino ratioReturn per unit of downside risk
-0.18
3.16

-3.34

Omega ratioGain probability vs. loss probability

0.98

1.38

-0.40

Calmar ratioReturn relative to maximum drawdown

-0.44

6.02

-6.46

Martin ratioReturn relative to average drawdown

-0.67

18.30

-18.97

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

XBIT vs. XBI - Sharpe Ratio Comparison

The current XBIT Sharpe Ratio is -0.33, which is lower than the XBI Sharpe Ratio of 2.30. The chart below compares the historical Sharpe Ratios of XBIT and XBI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

XBITXBIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.33

2.30

-2.63

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.48

0.02

-0.49

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.22

0.27

-0.49

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.22

0.36

-0.58

Drawdowns

XBIT vs. XBI - Drawdown Comparison

The maximum XBIT drawdown since its inception was -92.67%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for XBIT and XBI.

Loading charts...

Drawdown Indicators

XBITXBIDifference

Max Drawdown

Largest peak-to-trough decline

-92.67%

-63.89%

-28.78%

Max Drawdown (1Y)

Largest decline over 1 year

-39.43%

-9.72%

-29.71%

Max Drawdown (3Y)

Largest decline over 3 years

-78.56%

-32.99%

-45.57%

Max Drawdown (5Y)

Largest decline over 5 years

-87.21%

-54.71%

-32.50%

Max Drawdown (10Y)

Largest decline over 10 years

-90.72%

-63.89%

-26.83%

Current Drawdown

Current decline from peak

-91.19%

-24.96%

-66.23%

Average Drawdown

Average peak-to-trough decline

-70.10%

-20.93%

-49.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

25.84%

3.19%

+22.65%

Volatility

XBIT vs. XBI - Volatility Comparison

The current volatility for XBiotech Inc. (XBIT) is 6.87%, while SPDR S&P Biotech ETF (XBI) has a volatility of 9.26%. This indicates that XBIT experiences smaller price fluctuations and is considered to be less risky than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

XBITXBIDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.87%

9.26%

-2.39%

Volatility (6M)

Calculated over the trailing 6-month period

27.51%

20.18%

+7.33%

Volatility (1Y)

Calculated over the trailing 1-year period

51.89%

25.50%

+26.39%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

64.04%

32.18%

+31.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

75.32%

32.00%

+43.32%

Dividends

XBIT vs. XBI - Dividend Comparison

XBIT has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.34%.

PositionTTM20252024202320222021202020192018201720162015
XBI
SPDR S&P Biotech ETF		0.34%0.37%0.15%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%
XBIT
XBiotech Inc.		0.00%0.00%0.00%0.00%0.00%22.46%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

XBIT and XBI have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XBI has higher volatility (9.26%) compared to XBIT (6.87%). In terms of maximum drawdown, XBIT dropped -92.67% vs XBI's -63.89%.

XBI currently has the higher Sharpe Ratio (2.30 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for XBIT and XBI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer